Showing 1701-1710 of 20875 results for "".
- Emerging Sensor Technologies in Gastrointestinal Diagnostics: Spotlight on Ingestible Capsuleshttps://reachmd.com/news/emerging-sensor-technologies-in-gastrointestinal-diagnostics-spotlight-on-ingestible-capsules/2484114/The FireFLI capsule, a firefly-inspired ingestible biosensor, could enable earlier, noninvasive detection of intestinal inflammation and ischemia—potentially shifting time-to-diagnosis for conditions often recognized too late. According to
- Upadacitinib Demonstrates Rapid Improvement in AD Patients With Prurigo Noduleshttps://reachmd.com/news/upadacitinib-demonstrates-rapid-improvement-in-ad-patients-with-prurigo-nodules/2484113/A new interim analysis from the ADMIRE study, presented at the 2025 Fall Clinical Dermatology Conference, reported that upadacitinib yields rapid and sustained improvements in patients with moderate-to-severe atopic dermatitis (AD) complicated by prurigo nodules, o
- Skin Cancer Champions Launches Integrated Public, Private Communityhttps://reachmd.com/news/skin-cancer-champions-launches-integrated-public-private-community/2484106/The Skin Cancer Champions organization, led by dermatologists Emily Ruiz, MD, MPH, and Chrysalyne Schmults, MD, MSce, FAAD, announced the official launch of its integrated public and private community at skincancerchampions.org. The public platform expands the group’s reach by offering edu
- JAK Inhibition, Durable Repigmentation Strategies Among Vitiligo Advanceshttps://reachmd.com/news/jak-inhibition-durable-repigmentation-strategies-among-vitiligo-advances/2484093/Vitiligo has entered a new era of treatment innovation, according to Seemal Desai, MD, FAAD, who presented “Vitiligo Spotlight: A Closer Look at JAK Inhibitors” at the 2025 Fall Clinical Dermatology Conference. Dr. Desai characterized the current moment as a “Renaissance period” in vitilig
- Exploring Epigenetic Mechanisms in Asthma Recurrence: The Role of Brg1 in ILC2 Regulationhttps://reachmd.com/news/exploring-epigenetic-mechanisms-in-asthma-recurrence-the-role-of-brg1-in-ilc2-regulation/2484071/According to a report, preclinical researchers identify the chromatin remodeler Brg1 (Smarca4) as a central regulator of Group
- Demographic Considerations in Diagnosing Interstitial Ectopic Pregnancyhttps://reachmd.com/news/demographic-considerations-in-diagnosing-interstitial-ectopic-pregnancy/2484074/A new retrospective study out of Boston Medical Center has shed light on a persistent diagnostic challenge in reproductive medicine: the misdiagnosis of interstitial ectopic pregna
- Examining Nerandomilast Efficacy in Idiopathic Pulmonary Fibrosis: Insights from CHEST 2025https://reachmd.com/news/examining-nerandomilast-efficacy-in-idiopathic-pulmonary-fibrosis-insights-from-chest-2025/2484078/Nerandomilast (Jascayd) slowed forced vital capacity (FVC) decline over 52 weeks in the FIBRONEER‑IPF Phase 3 trial
- Interim Phase 2 Data Reveal Efficacy and Strategic Potential of KYV-101 in Generalized Myasthenia Gravishttps://reachmd.com/news/interim-phase-2-data-reveal-efficacy-and-strategic-potential-of-kyv-101-in-generalized-myasthenia-gravis/2484058/Interim Phase 2 data from Kyverna Therapeutics’ KYSA‑6 study indicate KYV‑101 produced early efficacy signals and an acceptable safety profile in generalized myasthenia gravis (gMG). KYV‑101 is a fully human, autologous CD19 CAR T‑cell therapy intended to induce deep
- Fancy Dress Contact Lenses: Clinical Insights for Safe Halloween Wearhttps://reachmd.com/news/fancy-dress-contact-lenses-clinical-insights-for-safe-halloween-wear/2484063/Decorative contact lenses surge before Halloween and are linked to a seasonal rise in ocular infections, corneal ulcers, and other vision‑threatening complications. According to a
- Discrepancies in Polio Vaccination Reporting: Implications for Surveillance and Laboratory Practiceshttps://reachmd.com/news/discrepancies-in-polio-vaccination-reporting-implications-for-surveillance-and-laboratory-practices/2484070/A recent report found a roughly 20% gap between self-reported and documented polio vaccination among survey participants—an inconsis